GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...

Ozempic is a drug for diabetes, but it's also being used off-label for weight loss. Its active ingredient has inspired a new ...

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...

PERSPECTIVES: The resurgence of Y2K skin-baring fashion trends coincides with the rise of prescription weight loss drugs like ...

Two clinical trials investigating semaglutide (Ozempic, Wegovy) as an early Alzheimer's treatment are expected to wrap up in ...

Weight loss with Ozempic or Wegovy can come with nausea, but avoiding certain foods and drinks can help patients manage the ...

Neither drug is considered as effective as the brand-name weekly injections sold for diabetes and weight loss as Ozempic and Wegovy by Novo Nordisk and Mounjaro and Zepbound by Eli Lilly. Still, ...

The world’s largest food and beverage company said it plans to launch a frozen food brand that will cater to consumers who ...

Recently published studies assert that Ozempic significantly increases the risk of developing a rare eye condition called non ...

Independence Blue Cross said starting Jan. 1 it will only be covering GLP-1 agonists — commonly sold under brand names like ...

But in an increasingly competitive market for weight loss drugs, these are not the only options for people looking to lose ...

Maryland’s Medicaid program now offers partial coverage of popular obesity drugs, with the state spending more than $68 ...